Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Denise D. Darrah"'
Autor:
Denise D. Darrah, Anne M. Wallace, David R. Vera, Carl K. Hoh, Gery Schulteis, Scott J. Ellner
Publikováno v:
Annals of Surgical Oncology. 14:913-921
Lymphoseek is a molecular imaging agent specifically designed for sentinel lymph node mapping. We conducted a phase I clinical trial in which Lymphoseek was compared with filtered [(99m)Tc]sulfur colloid (fTcSC) for melanoma sentinel lymph node detec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341b5b252119afe0b194f345af82d52f
https://doi.org/10.1245/s10434-006-9099-4
https://doi.org/10.1245/s10434-006-9099-4
Autor:
Denise D. Darrah, Malcolm S. Mitchell, June Kan-Mitchell, Vicky Jones, Philip R. Morrow, Matthew F. Mescher
Publikováno v:
Clinical Cancer Research. 10:76-83
Purpose: The purpose of this research was to determine the toxicity and immunological activity of large multivalent immunogen (LMI), a preparation of tumor cell membranes affixed to amorphous silica microbeads, in patients with melanoma. Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc4911bc70fb6408ab1e1f9d2815373
https://doi.org/10.1158/1078-0432.ccr-0689-3
https://doi.org/10.1158/1078-0432.ccr-0689-3
Publikováno v:
Annals of Surgical Oncology. 10:531-538
Lymphoseek is a new radiopharmaceutical that accumulates in lymphatic tissue by binding to a receptor that resides on the surface of macrophage cells. We conducted a phase I clinical trial in which Lymphoseek was compared with filtered [(99m)Tc]sulfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcd5d1fe544fd479d146073df2884edd
https://doi.org/10.1245/aso.2003.07.012
https://doi.org/10.1245/aso.2003.07.012
Autor:
Karl K. Limmer, Gery Schulteis, Carl K. Hoh, Denise D. Darrah, David R. Vera, Anne M. Wallace
Lymphoseek is a receptor-binding radiopharmaceutical specifically designed for sentinel lymph node (SLN) mapping. We conducted a clinical trial which measured the injection site clearance and sentinel lymph node accumulation after a single intraderma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c99aa28fcb7bd1b31982c83ad8027e
https://europepmc.org/articles/PMC4201841/
https://europepmc.org/articles/PMC4201841/
Autor:
Jeanette Méndez, Carl Kalon Hoh, David R. Vera, Anne M. Wallace, Richard C. Orahood, Antonia Woehnl, Denise D. Darrah
Publikováno v:
From Local Invasion to Metastatic Cancer ISBN: 9781603270861
Sentinel lymph node biopsy is performed with increasing frequency in patients undergoing surgery for early-stage cancer to avoid unnecessary lymphadenectomy in patients whose sentinel node is negative for metastatic disease. Mapping of the sentinel n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec7859067910473d5c2d433f85f824d6
https://doi.org/10.1007/978-1-60327-087-8_12
https://doi.org/10.1007/978-1-60327-087-8_12
Lymphoseek™ is a molecular imaging agent specifically designed for sentinel lymph node (SLN) mapping. We conducted a Phase I trial which measured the injection site clearance and sentinel lymph node accumulation after a single intra-dermal injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3132cf9d6c73cf6ce96bbbb0e075ed3f
https://europepmc.org/articles/PMC4189800/
https://europepmc.org/articles/PMC4189800/
Autor:
David R. Vera, Gery Schulteis, Denise D. Darrah, Anne M. Wallace, Carl K. Hoh, Scott J. Ellner
Publikováno v:
Nuclear medicine and biology. 30(8)
[ 99m Tc]DTPA-mannosyl-dextran is a receptor-binding radiopharmaceutical specifically designed for sentinel lymph node mapping. The purpose of this study was to test the biodistribution and safety of [ 99m Tc]DTPA-mannosyl-Dextran at different molar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77daf9d1a4eedf650df62b71d10947e1
https://pubmed.ncbi.nlm.nih.gov/14698783
https://pubmed.ncbi.nlm.nih.gov/14698783
Publikováno v:
Cancer investigation. 20(5-6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1c6746c5da7c3cc913a1577b60f499
https://pubmed.ncbi.nlm.nih.gov/12197233
https://pubmed.ncbi.nlm.nih.gov/12197233
Autor:
Johanna Melo-Cardenas, Charles E. Prussak, Denise D. Darrah, Mauricio Urquiza, B. Cox, Thomas J. Kipps, Jose Sandoval-Sus, Januario E. Castro
Publikováno v:
Journal of Clinical Oncology. 27:e14552-e14552
e14552 Background: Transduction of chronic lymphocytic leukemia (CLL) cells with a replication-defective adenovirus (Ad) encoding recombinant CD154 (Ad-ISF35) induces expression of death receptors and Bid via a P53-independent pathway involving induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47e713930873be9e611bc04529434494
https://doi.org/10.1200/jco.2009.27.15_suppl.e14552
https://doi.org/10.1200/jco.2009.27.15_suppl.e14552
Autor:
Denise D. Darrah, Johanna Melo-Cardenas, Thomas J. Kipps, R.S. Pakbaz, Mauricio Urquiza, Jose Sandoval-Sus, Charles E. Prussak, Januario E. Castro
Publikováno v:
Journal of Clinical Oncology. 27:3003-3003
3003 Background: Transduction of chronic lymphocytic leukemia (CLL) cells with replication-defective adenovirus (Ad) encoding a genetically engineered, membrane-stablized CD154 (ISF35) converts transduced, and “bystander” non-transduced, CLL cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef0d6838032011cd36598dc07d3c59bf
https://doi.org/10.1200/jco.2009.27.15_suppl.3003
https://doi.org/10.1200/jco.2009.27.15_suppl.3003